Cargando…
Applying Choosing Wisely: Antinuclear Antibody (ANA) and Sub-Serology Testing in a Safety Net Hospital System
OBJECTIVE: In 2013, the American College of Rheumatology (ACR) participated in the Choosing Wisely campaign and devised a recommendation to avoid testing antinuclear antibody (ANA) subserologies without a positive ANA and clinical suspicion of disease. The goals of our study were to describe ANA and...
Autores principales: | Davis, Lisa Anne, Goldstein, Barbara, Tran, Vivian, Keniston, Angela, Yazdany, Jinoos, Hirsh, Joel, Storfa, Amy, Zell, JoAnn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Open
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4740967/ https://www.ncbi.nlm.nih.gov/pubmed/26862352 http://dx.doi.org/10.2174/1874312901409010082 |
Ejemplares similares
-
Can Antinuclear Antibodies (ANA) be Monoclonal?
por: Biederman, Laura, et al.
Publicado: (2021) -
The Past, Present, and Future in Antinuclear Antibodies (ANA)
por: Irure-Ventura, Juan, et al.
Publicado: (2022) -
Choosing Wisely
por: Strote, Jared
Publicado: (2022) -
A Rare Case of Antinuclear Antibody (ANA)-Negative Lupus Nephritis
por: Bakshi, Nayaab, et al.
Publicado: (2023) -
Choosing Wisely
Statins
Publicado: (2020)